SLC41A3 and hepatocellular carcinoma: Consensus-clustering analysis with the TCGA HCC data for the sorafenib-response targets, SLC41A3, SEC61A1, LRP4, PPM1G, and HSP90AA1, showed that K = 2 enabled the best grouping (Figures 9(a)–9(c)).